article · The Lancet Infectious Diseases

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

Antoine Nkuba-Ndaye
Tamara Tovar-Sanchez
Richard Kitenge
Abdoulaye Touré
Anaïs Legand
Noëlla Mulopo-Mukanya
Guillaume Thaurignac
Junior Bulabula-Penge
Pierre Formenty
Audrey Lacroix
Angele Dilu-Keti
François Edidi-Atani
Placide Mbala‐Kingebeni
Daniel Mukadi‐Bamuleka
Éric Delaporte
Eddy Kinganda-Lusamaki
Divine Kitsa-Mutsumbirwa
Martine Peeters
Steve Ahuka‐Mundeke
Bernice Danga-Yema
Ahidjo Ayouba
Nelson Kambale-Sivihwa
Nella Bisento-Ngafa
François Eddi-Atani
Fabrice Mambu Mbika
Gabriel Kabamba Lungenyi
Meris Matondo Kiamfumu
Julie Boullin
Eric Panzi-Kalunda
Callixte Kakule-Sadiki
Guillaume Kambale-Kasyamboko
Sheila Kavira-Muhesi
Eli Kavoyo-Mbayayi
Fyfy Mbelu-Matulu
Elias Mumbere-Kalemekwa
Defao
Grace Paluku-Salambongo
Ekoko
Mamadou Saliou Kalifa Diallo
Jean‐Jacques Muyembé‐Tamfum
Raphaël Pelloquin
Angèle Dilu-Keti

20238 citations

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/s1473-3099(23)00552-2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

In plain language

Research topics

Read the original research

Discuss this research